To investigate the efficacy of the bleb needling revision (BNR) procedure with the adjunctive use of 5-Fluorouracil (5-FU) in encapsulated bleb after unsuccessful trabeculectomy. Methods: We reviewed 16 eyes of 15 subjects who underwent BNR procedure due to encapsulated bleb after unsuccessful trabeculectomy. Demographic data, type of glaucoma, intraocular pressure (IOP) values of pre-BNR, IOP values of post-BNR at first day, first week and first month, follow up time and complications were recorded from patients' files, retrospectively. Results: The mean follow up time was 53.1 ± 26.4 weeks. The average time between previous unsuccessful trabeculectomy and BNR was 11.12 ± 8.79 weeks. The mean IOP of pre-BNR was 26.0±4.4 mmHg and significantly decreased to 12.4 ± 5.0 mmHg post-BNR at the first day (p < 0.001). The mean IOP values of post-BNR at the first week was 13.3 ± 4.9 mmHg and at the first month was 14.8 ± 4.8 mmHg. According to the mean IOP of pre-BNR, the mean IOP values of post-BNR at the first week and at the first month were significantly lower (p < 0.001 and p < 0.001, respectively). Seven (44%) eyes were achieved success and eight (50%) eyes were achieved qualified success. One (6%) eye was classified as the failure. Conclusion: The bleb needling revision procedure with the adjunctive use of 5-FU in encapsulated bleb after unsuccessful trabeculectomy is a simple, useful and repeatable method to restore the dysfunctional bleb.
The European Research Journal 2019;5 (6) :990-995 rabeculectomy remains the gold standard surgical procedure in cases that intraocular pressure (IOP) couldn't control with antiglaucomatous medication [1] . Trabeculectomy is a very effective procedure to reduce IOP at the early postoperative period. Nevertheless, its efficiency may decreases over time for some complications such as dysfunctional blebs. Localization of the bleb, episcleral fibrosis, and bleb encapsulation are the bleb-related reasons for the failure of primary filtration surgery [2] .
Encapsulated bleb usually seen within 2-8 weeks after filtration surgery and the incidence is reported between 2.5% and 29% in previous studies [3, 4] . Encapsulated bleb was characterized as an elevated, smooth surfaced, tense, thickened, dome-shaped fibrotic membrane. The mechanism of development of encapsulated bleb is not well understood and many factors are responsible for its formation. The encapsulated bleb wall that limiting aqueous outflow is composed of a fibrous, collagenous connective tissue which is histopathologically produced as a result of fibroblastic proliferation [5] . Hence, inflammatory reaction and fibroblastic activity may increase the risk of developing encapsulated bleb [6] .
The method of Bleb Needling Revision (BNR) which was first described by Ferrer in 1941, is now frequently preferred after unsuccessful filtration surgery [7] . The adjunctive use of antifibrotic agents such as 5-fluorouracil (5-FU) and mitomycin-C (MMC) in BNR is suggested to increase the rate of success of the procedure. 5-FU and MMC inhibit the scarring tissue formation and the proliferation of the fibroblasts which are the primary reasons for dysfunction of the blebs. Thus, BNR with antifibrotic agent is a simple and reliable method that can be an alternative treatment after dysfunctional blebs and reduce the IOP without causing additional healthy conjunctival surface loss and prevents patients from another glaucoma surgery. BNR has very good results but many factors such as age, the number of antiglaucomatous drug used before, history of previous ocular surgery, type of glaucoma, use of antimetabolite in primary filtration surgery and bleb morphology may affect the success of the procedure.
In addition, MMC has higher potency according to 5-FU but more complications have been reported due to use of MMC [1, 6] . Therefore, we prefer to perform the procedure with 5-FU. In this study, we aimed to evaluate the efficiency of the BNR procedure in patients who underwent BNR with adjunctive use of 5-FU after unsuccessful trabeculectomy.
METHODS
Sixteen eyes of 15 subjects who underwent BNR due to encapsulated bleb after unsuccessful trabeculectomy (IOP ≥ 21 mmHg) in Necmettin Erbakan University, Meram School of Medicine, Department of Ophthalmology between March 2015-March 2017 were evaluated retrospectively. The study was approved by the local ethics committee (No:2018/1156) and followed the tenets of the Declaration of Helsinki. Demographic data, type of glaucoma, IOP values of pre-BNR, IOP values of post-BNR at the first day, the first week and the first month which were measured by Goldmann applanation tonometry, follow up time and complications were recorded from patients files.
The BNR procedure was performed in the operation room using a 27-gauge needle with adjunctive use of 5-FU by two surgeons (MO and EM). After topical anesthetic (Proparacaine Hydrochloride 0.5%), 5% povidone-iodine solutions were instilled into the eye. A 27-gauge needle was inserted into the subconjunctival space to the tight Tenon's capsule around the bleb on the opposite site of the scleral flap, puncture the adherent tissue and lift the scleral flap. The flap was lifted with gentle sideto-side movement, breaking episcleral adhesions until the bleb is reformed. If simple flap dissection failed to form a nonsatisfactory bleb, the needle can be passed under the scleral flap into the anterior chamber. Then, the needle was removed and 5 mg (0.2 ml of 25 mg/ml solution) of 5-FU was subconjunctivally injected superior to the bleb. At the end of the procedure, antibiotic drops (moxifloxacin 0.5%) were instilled into the eye.
History of previous unsuccessful trabeculectomy surgery with or without antifibrotic agents, the presence of dysfunctional blebs due to encapsulated bleb, the presence of patent iridectomy were the inclusion criterion. History of previous multiple trabeculectomies or filtration surgery other than trabeculectomy, the presence of non-patent iridectomy, the presence of corneal epithelial complications, and leaky blebs were the exclusion criterion. The BNR procedure was considered as success IOP < 21 mmHg without antiglaucomatous medication; qualified success defined as IOP < 21 mmHg with antiglaucomatous medication and failure defined as IOP ≥ 21 mmHg with antiglaucomatous medication.
Statistical Analysis
SPSS for Windows (version 17; SPSS Inc, Chicago, Illinois, USA) were used for the analysis. The paired t-test was used to compare IOP. A P value < 0.05 was considered as significant.
RESULTS
Sixteen eyes of 15 subjects were included in the study. Three (20%) subjects were female, 12 (80%) subjects were male. The age of subjects ranged (Table 1 ). All eyes were underwent conventional trabeculectomy previously and six of them were with adjunctive use of 5-FU (Table 2 ). There were nine (56%) eyes with primary openangle glaucoma (POAG) and seven (44%) eyes with secondary glaucoma such as one eye had neovascular glaucoma, one eye had chronic uveitis, two eyes had pseudoexfoliation glaucoma, three eyes had glaucoma following serious trauma to the globe ( Table 1 ). The average time between previous unsuccessful trabeculectomy and BNR ranged between 4-29 weeks and the mean time was 11.12 ± 8.79 weeks. The mean IOP of pre-BNR was 26.0 ± 4.4 mmHg and significantly decreased to 12.7 ± 4.4 mmHg post-BNR at the first day (p < 0.001). The mean IOP values of post-BNR at the first week were 13.3 ± 4.9 mmHg and at the first month was 14.8 ± 4.8 mmHg (Figure 1 ). The mean follow up time was 53.1 ± 26.4 weeks (range 25 to 124 weeks). According to the mean IOP of pre-BNR, the mean IOP values of post-BNR at the first week and at the first month were significantly lower (p < 0.001 and p < 0.001, respectively). Seven (44%) eyes were achieved success and eight (50%) eyes were achieved qualified success. One (6%) eye was classified as failure. Complications such as lateonset bleb leakage in two eyes and bullous keratopathy in one eye observed in three (19%) eyes as shown in Table 2 .
DISCUSSION
One of the most important factors that determining the success of trabeculectomy and bleb function is the degree of healing process in the filtration zone [8, 9] . A variety of risk factors such as excessive surgical trauma and increased inflammatory process after an early period of filtration surgery which is related to the development of encapsulated bleb have been reported in the literature [5, 6] . This suggests that these risk factors are not a definite etiology for the presence of encapsulated bleb formation [6] . Even so, surgical trauma and increased postoperative inflammation may probably lead to increase the risk of encapsulated bleb [10] . Although there is currently no definitive treatment to prevent bleb failure and encapsulated bleb. Indeed, many drugs and different treatment methods are still being studied. One of the drugs used to inhibit fibroblastic proliferation and enhance the success of the filtration surgery by allowing the bleb to remain functional is 5-FU. The use of 5-FU adjunctive with filtration surgery or BNR procedure and also injections after filtration surgery can be done. Many researchers have reported the efficacy of the BNR with 5-FU in unsuccessful bleb after filtration surgery [11, 12] . Notably, IOP decreased by an average of 10.5 mmHg (44.8%) immediately after the BNR procedure in the study of Kapasi and Birt [11] . Broadway et al. [13] showed 47% success rate in encapsulated bleb after BNR with adjunctive 5-FU and it was reported that the mean IOP being reduced from 26.5 mmHg to 15 mmHg after a median of 1 BNR procedure. Also, the mean IOP was lower in the BNR with 5-FU group (12.1 ± 2.8 mmHg) compared to the medical treatment group (15.1 ± 2.1 mmHg) in the study of Suzuki and Susanna [14] . In our study, it was found that the mean IOP values decreased by 51% (reduced from 26.0 ± 4.4 mmHg to 12.7 ± 4.4 mmHg) at the postoperative 1st month compared to the mean preoperative IOP values.
MMC is another antifibrotic agent in filtration surgery and in BNR procedure but more complications have been reported due to use of MMC [15, 16] . In a retrospective study comparing MMC and 5-FU, there was no difference in success between using MMC and 5-FU, and early postoperative IOP was reported to be the only predictor of success [17] . Complications such as hemorrhage, infection, late-onset bleb leakage, hypotonia, choroidal detachment and suprachoroidal hemorrhage can occur with rarely due to BNR procedure. Anand et al. [18] have reported that MMC is a more patent antifibrotic agent but also they reported that in the MMC group, blebitis and late bleb leakage were reported more frequently than in the 5-FU group. In this study, we observed late-onset bleb leakage in two eyes and bullous keratopathy in one eye.
Previous studies have reported that the short time between previous unsuccessful trabeculectomy and the BNR procedure has an adverse effect on bleb function [19, 20] . Shetty et al. [21] suggested that immediate BNR after trabeculectomy could be unsuccessful due to the ongoing episcleral inflammation caused by the previous surgery. On the other hand, Gutierrez-Ortiz et al. [20] proposed that the success of the BNR procedure was highly correlated with glaucoma filtration surgery performed less than 4 months previously. In this study, the time elapsed between previous trabeculectomy and BNR procedure was ranged 4 to 29 weeks and additionally in twelve eyes the time was ≤ 10 weeks. Indeed, we achieved success in seven of sixteen eyes and in eight eyes antiglaucomatous medication is needed after the BNR procedure (qualified success). The overall success rate of the BNR procedure in the study was 94%.
Moreover, there may be an eventual decrease in efficiency in the BNR procedure over time. IOP > 30 mmHg before the procedure, high IOP after the procedure, lack of use antimetabolite in previous filtration surgery, type of glaucoma are the risk factors that affect the efficiency of the BNR procedure [22] . Generally, repeated BNR with adjunctive 5-FU provide revive of filtration in dysfunctional bleb and prevent other surgery [23] . Indeed, additional surgery may be needed in some cases. Patients with neovascular glaucoma or secondary glaucoma (uveitic glaucoma, traumatic glaucoma, pseudoexfoliation glaucoma, etc.) constitute a high-risk group. In our study, in one risky eye which had neovascular glaucoma IOP couldn't control with antiglaucomatous medication after the BNR procedure and Ahmed glaucoma valve implantation had to be performed.
CONCLUSION
In conclusion, despite limitations of this study such as small sample size, retrospective design, and the absence of the control group, the BNR procedure with adjunctive use of 5-FU effectively reduces IOP or decreases the number of antiglaucomatous drugs in patients with encapsulated bleb and it is a simple, effective and repeatable method for the failure of bleb filtration after trabeculectomy.
